Vimarsana
Biggest News Aggregation in the World

Group Biomedical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Group Biomedical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Group Biomedical Sciences Today - Breaking & Trending Today

Galapagos NV: Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn's disease - Vimarsana News

Galapagos NV: Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn's disease

Published: February 8, 2023

The two induction cohorts missed the co-primary endpoints of clinical remission and endoscopic response at Week 10In the maintenance phase, filgotinib 200mg once daily achieved the co-primary endpoints

Source: finanznachrichten.de
Related Topics:
Region FlamandeUnited KingdomNorthern IrelandGreat BritainDaniele DambrosioVan GijselSandra CauwenberghsMarieke VermeerschSchwierige ZeitenElisa ChenaillerGastroenterology Department Of The University Hospital LeuvenGroup Biomedical SciencesEuropean ParliamentGilead Sciences IncExchange CommissionJapanese Ministry Of HealthEuropean UnionUniversity Of LeuvenMarketing Authorization ApplicationPatient Reported OutcomeSimple Endoscopic ScoreResearch DirectorGastroenterology DepartmentUniversity Hospital LeuvenTherapeutic Area Head
Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn's disease - Vimarsana News

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn's disease

Published: February 8, 2023

Investegate announcements from Galapagos NV, Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease

Source: investegate.co.uk
Related Topics:
Region FlamandeUnited KingdomNorthern IrelandGreat BritainDaniele DambrosioVan GijselSandra CauwenberghsMarieke VermeerschElisa ChenaillerGastroenterology Department Of The University Hospital LeuvenGroup Biomedical SciencesEuropean ParliamentGilead Sciences IncExchange CommissionJapanese Ministry Of HealthEuropean UnionUniversity Of LeuvenMarketing Authorization ApplicationPatient Reported OutcomeSimple Endoscopic ScoreResearch DirectorGastroenterology DepartmentUniversity Hospital LeuvenTherapeutic Area HeadDisease Activity Index